Patent · US Active

Anti-malaria vaccine

US9279006B2 · kind B2 · utility

0Cited by

7References

4Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventor

Joseph Cohen · Brussels, BE

Key dates

Filing date	Jun 29, 2006
Grant date	Mar 8, 2016
Priority date	—
Expiry date	Oct 13, 2028

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There is provided, inter alia, a method for the prophylaxis of productive malaria infection in travelers to endemic regions comprising the administration of suitable amounts of a formulation comprising a Plasmodium antigen or an immunogenic fragment or derivative thereof and an adjuvant, comprising a lipid A derivative and a saponin in a liposome formulation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.